Severe chronic pain in opioid-tolerant pediatric patient (11 years of age and older)

Severe chronic pain in an opioid-tolerant pediatric patient (11 years of age and older) is a persistent, high-intensity pain state affecting the central and peripheral somatosensory systems that arises from malignant diseases, major trauma, or severe chronic illnesses It is clinically defined by ongoing or recurrent pain of sufficient magnitude and duration to require continuous, around-the-clock opioid analgesia when non-opioid regimens and immediate-release options fail to provide adequate con...

Severe chronic pain in an opioid-tolerant pediatric patient (11 years of age and older) is a persistent, high-intensity pain state affecting the central and peripheral somatosensory systems that arises from malignant diseases, major trauma, or severe chronic illnesses It is clinically defined by ongoing or recurrent pain of sufficient magnitude and duration to require continuous, around-the-clock opioid analgesia when non-opioid regimens and immediate-release options fail to provide adequate con...

Severe chronic pain in an opioid-tolerant pediatric patient (11 years of age and older) is a persistent, high-intensity pain state affecting the central and peripheral somatosensory systems that arises from malignant diseases, major trauma, or severe chronic illnesses

Opioid tolerance denotes a physiological adaptation resulting from sustained prior opioid therapy—frequently defined by meeting specific daily equianalgesic baselines without intolerable adverse events—which reduces systemic responsiveness and necessitates careful analgesic maintenance to prevent under-treatment or dangerous complications like respiratory depression in this adolescent cohort

Opioid tolerance denotes a physiological adaptation resulting from sustained prior opioid therapy—frequently defined by meeting specific daily equianalgesic baselines without intolerable adverse events—which reduces systemic responsiveness and necessitates careful analgesic maintenance to prevent under-treatment or dangerous complications like respiratory depression in this adolescent cohort